Cargando…

Diagnostic and Prognostic Values of Cardiopulmonary Exercise Testing in Cardiac Amyloidosis

Cardiac amyloidosis (CA) is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart, resulting in increased myocardial stiffness, and restrictive heart wall chamber behavior. Its diagnosis among patients hospitalized for cardiovascular diseases is becoming incre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banydeen, Rishika, Monfort, Astrid, Inamo, Jocelyn, Neviere, Remi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207317/ https://www.ncbi.nlm.nih.gov/pubmed/35734274 http://dx.doi.org/10.3389/fcvm.2022.898033

Ejemplares similares

Determinants of ventilatory inefficiency in transthyretin cardiac amyloidosis: The role of excessive ventilatory drive
por: Monfort, Astrid, et al.
Publicado: (2022)

Cerebral Ischemic Events: An Overlooked Complication of Transthyretin Cardiac Amyloidosis in Afro-Caribbean Patients
por: Banydeen, Rishika, et al.
Publicado: (2022)

Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients
por: Monfort, Astrid, et al.
Publicado: (2022)

Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry
por: Banydeen, Rishika, et al.
Publicado: (2023)

The ventilatory component of the muscle metaboreflex is overstimulated in transthyretin cardiac amyloidosis patients with poor aerobic capacity
por: Monfort, Astrid, et al.
Publicado: (2023)

Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis
por: Bi, Xiao, et al.
Publicado: (2022)

Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis
por: Scheel, Paul J., et al.
Publicado: (2022)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis
por: Zhang, Yang, et al.
Publicado: (2021)

Electrocardiogram Characteristics and Prognostic Value in Light-Chain Amyloidosis: A Comparison With Cardiac Magnetic Resonance Imaging
por: Guo, Xinli, et al.
Publicado: (2021)

Feasibility of remote technical support for electrophysiological ablation procedures during the current COVID-19 pandemic
por: Müssigbrodt, Andreas, et al.
Publicado: (2021)

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact
por: Cariou, Eve, et al.
Publicado: (2021)

Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis
por: Cersosimo, Angelica, et al.
Publicado: (2023)

Risk stratification in transthyretin-related cardiac amyloidosis
por: Scirpa, Riccardo, et al.
Publicado: (2023)

Differential Evaluating Effect on Exercise Capacity of Cardiopulmonary Exercise Testing and Treadmill Exercise Testing in Post-percutaneous Coronary Intervention Patients
por: Gao, Yifan, et al.
Publicado: (2021)

Diagnostic and prognostic value of cardiac imaging in amyloidosis
por: Vidal-Perez, Rafael, et al.
Publicado: (2020)

Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

Breathing pattern and pulmonary gas exchange in elderly patients with and without left ventricular dysfunction—modification with exercise-based cardiac rehabilitation and prognostic value
por: Eser, Prisca, et al.
Publicado: (2023)

Chronotropic incompetence can limit exercise tolerance in COPD patients with lung hyperinflation
por: Hulo, Sébastien, et al.
Publicado: (2016)

Cardiopulmonary exercise test: A 20-year (2002-2021) bibliometric analysis
por: Song, Lei, et al.
Publicado: (2022)

Cardiac Amyloidosis: A Review of Current Imaging Techniques
por: Razvi, Yousuf, et al.
Publicado: (2021)

The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients
por: Yue, Xiuzheng, et al.
Publicado: (2022)

Corrigendum: Prognostic implication of longitudinal changes of left ventricular global strain after chemotherapy in cardiac light chain amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

Sex differences in heart failure patients assessed by combined echocardiographic and cardiopulmonary exercise testing
por: Rozenbaum, Zach, et al.
Publicado: (2023)

Comparison Between Treadmill and Bicycle Ergometer Exercises in Terms of Safety of Cardiopulmonary Exercise Testing in Patients With Coronary Heart Disease
por: Ren, Chuan, et al.
Publicado: (2022)

Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis
por: Agha, Ali M., et al.
Publicado: (2021)

Diagnosis of Cardiac Amyloidosis Using a Radiomics Approach Applied to Late Gadolinium-Enhanced Cardiac Magnetic Resonance Images: A Retrospective, Multicohort, Diagnostic Study
por: Zhou, Xi Yang, et al.
Publicado: (2022)

Pilot Study of F18-Florbetapir in the Early Evaluation of Cardiac Amyloidosis
por: Sperry, Brett W., et al.
Publicado: (2021)

The Prognostic Value of Cardiac Biomarkers and Echocardiography in Critical COVID-19
por: Zwaenepoel, Bert, et al.
Publicado: (2021)

Soluble urokinase plasminogen activator receptor levels are predictive of COVID-19 severity in Afro-Caribbean patients
por: Padelli, Mael, et al.
Publicado: (2022)

Branched-Chain Amino Acid Catabolism and Cardiopulmonary Function Following Acute Maximal Exercise Testing in Adolescents
por: Gumus Balikcioglu, Pinar, et al.
Publicado: (2021)

The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update
por: Khanna, Shaun, et al.
Publicado: (2020)

Diagnosis of Cardiac Involvement in Amyloid A Amyloidosis by Cardiovascular Magnetic Resonance Imaging
por: Chamling, Bishwas, et al.
Publicado: (2021)

Cardiac Biomarker Levels and Their Prognostic Values in COVID-19 Patients With or Without Concomitant Cardiac Disease
por: Yu, Jia-Sheng, et al.
Publicado: (2021)

Fitter Fontans for future—Impact of physical exercise on cardiopulmonary function in Fontan patients
por: Weigelt, Annika, et al.
Publicado: (2022)

Time of the low-level cardiopulmonary exercise test does not affect the evaluation of acute myocardial infarction in stable status
por: Zhao, Lanting, et al.
Publicado: (2022)

Reference values for peak oxygen uptake: cross-sectional analysis of cycle ergometry-based cardiopulmonary exercise tests of 10 090 adult German volunteers from the Prevention First Registry
por: Rapp, Daniel, et al.
Publicado: (2018)

Incidence and effect of secondary cardiac amyloidosis on outcomes of patients with t(11;14) multiple myeloma
por: Wang, Jinghua, et al.
Publicado: (2022)

Clinical challenges in the management of cardiac amyloidosis complicating aortic stenosis and coronary artery disease
por: Raval, Maharshi, et al.
Publicado: (2022)

Screening approaches to cardiac amyloidosis in different clinical settings: Current practice and future perspectives
por: Caponetti, Angelo Giuseppe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d3qpsbcjfsjb1vhj841752t4oo